Rocket Lab Files Pro Forma Financials for $7.6B Iridium Acquisition, Reveals $3.6B Bridge Loan
RKLB has more than doubled off its 52-week low of $37.57.
Summary
Rocket Lab filed pro forma financials for its $7.6 billion Iridium acquisition, revealing a $3.6 billion bridge loan at 8% interest and pro forma net losses of $154.7M for H1 2026.
Key Events · M&A and Partnerships · RKLB
-
Pro Forma Financials Filed
Combined pro forma revenue of $878.7M for H1 2026 and $1.47B for FY2025; pro forma net loss of $154.7M for H1 2026 and $203.0M for FY2025.
-
$3.6B Bridge Loan Disclosed
364-day senior secured bridge term loan from Deutsche Bank and Wells Fargo at approximately 8.0% effective interest rate, adding $141.4M interest expense for H1 2026 and $285.7M for FY2025.
-
Purchase Price Allocation
Total estimated consideration of $7.59B: $2.86B cash, $2.86B stock (41.26M shares at $69.33 VWAP), $93.8M equity awards, and $1.77B debt payoff. Goodwill of $2.20B and intangibles of $4.33B (including $3.32B spectrum).
-
Exchange Ratio Mechanics
Exchange ratio of 0.4000 if RKLB price ≤ $67.50; 0.2400 if ≥ $112.50; variable between $67.50 and $112.50. Current 10-day VWAP of $69.33 yields ratio of 0.3894.
Analysis · RKLB · Manufacturing
This 8-K provides the first detailed pro forma financial statements for the pending Iridium acquisition, quantifying the combined entity's revenue, losses, and balance sheet. It also discloses the $3.6 billion bridge loan facility at an 8% effective interest rate, which will significantly increase interest expense and contribute to pro forma net losses of $154.7 million for H1 2026 and $203.0 million for FY2025. The purchase price allocation shows $2.2 billion in goodwill and $4.3 billion in intangible assets, including $3.3 billion for spectrum. These details give investors a clearer picture of the deal's financial impact, including the substantial debt burden and dilution from issuing 41.3 million shares.
How filings like this one have moved
In the 30 days to Oct 17, 2026, 36.8% of the 985 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.66%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RKLB was trading at $80.37 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $48.6B. The 52-week trading range was $37.57 to $151.00. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.